It sure is interesting how the #2 pick has done so much better than the #1 buy and hold. I know which stock I wish I had bought and it isn't NNVC. There's a big difference between biotechs that actually get to clinical trials and those that never do.
Do you ever have one of those nightmares where you have to get someplace or do something and you keep getting thwarted and you never make any progress? That's what's it like holding NNVC stock.